key: cord-0871719-26r9bcyr
authors: Deeks, Jonathan J
title: Letter to the Editor regarding Leber W, Lammel O, Siebenhofer A, Redlberger-Fritz M, Panovska-Griffiths J, Czypionka T. Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2)
date: 2021-09-12
journal: EClinicalMedicine
DOI: 10.1016/j.eclinm.2021.101106
sha: 9dc13bb83649ebf133fb71ca3d7f8d04e69b8229
doc_id: 871719
cord_uid: 26r9bcyr

nan

Reporting on the accuracy of lateral flow antigen tests (LFT) for SARS-CoV-2 in primary care, Leber and colleagues stated the tests to have a sensitivity of 95.4% (judged comparable to RT-PCR) and specificity of 89.1% (lower than clinically validated tests reported to the European Centre for Disease Prevention and Control) [1] .

The high sensitivity is created by a flaw in the study design, as is the low specificity. Incomplete verification linked to the result of the LFT has led to the sensitivity value being an overestimate and the specificity value an underestimate [2] .

The study prospectively recruited 2562 individuals presenting to primary care with influenza like symptoms, all of whom received the LFT, but only a minority were verified with RT-PCR. All 1525 intentionally excluded from verification were negative on the LFT, so only 1 in 8 (12.5%) LFT negatives were verified. Exclusion of these LFT negatives impacts on the numbers of true negatives and false negatives in the 2 £ 2 table À the total of these groups being one eighth of what should have been counted. Undercounting false negatives overestimates sensitivity, undercounting true negatives underestimates specificity.

Verification of only a random sample of test negatives is a valid approach which can be used to make a study efficient, but the sample must be representative and the analysis adjusted for the sampling fraction [3, 4] . For example, when a random sample of one in eight of the test negatives were verified, the estimates of sensitivity and specificity can be computed by multiplying the numbers of true negatives and false negatives by eight (computation of confidence intervals is more complex and requires use of sampling theory). If this correction was applied here, the sensitivity would be 72.2% rather than 95.4%, and the specificity would be 98.5% rather than 89.1% -both values in line with other evaluations of professionals using these tests in symptomatic people.

However, here the sample was not random, but those who were not verified "presented with signs and symptoms suggesting an alternative clinical diagnosis". Whilst the numbers above give an indication of the magnitude of the bias, no confidence should be placed in these 'corrected' figures as it is unlikely that those LFT negatives verified with RT-PCR are representative of all LFT negatives.

Sadly, this study flaw is irreparable and is likely to have a large impact, such that the findings of this study must be disregarded.

Yours Jonathan J Deeks PhD CStat FMedSci, Professor of Biostatistics, University of Birmingham, UK

Comparing the diagnostic accuracy of point-of-care lateralflow antigentesting for SARS-CoV-2 with RT-PCR in primary care (REAP-2)

Assessment of diagnostic tests when disease verification is subject to selection bias

Van den Bruel A. Development of practical recommendations for diagnostic accuracy studies in low-prevalence situations

Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: testing frequency and public health messaging is key

This is an open access article under the CC BY-NC-ND license

Contents lists available at ScienceDirect EClinicalMedicine journal homepage

The author has no conflict of interest to declare.